Publications by authors named "Anne Chester"

Claim this Profile
L
Lenacapavir: A Novel, Potent, and Selective First-in-Class Inhibitor of HIV-1 Capsid Function Exhibits Optimal Pharmacokinetic Properties for a Long-Acting Injectable Antiretroviral Agent.
Raju Subramanian, Jennifer Tang, Jim Zheng, Bing Lu, Kelly Wang, Anne Chester

Mol Pharm· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurotoxicity of an Hepatitis B Virus (HBV) Transcript Inhibitor in 13-Week Rat and Monkey Studies.
April D Lake, Kevin Holsapple, Tanya McDonnell, Joseph C Arezzo, Ricardo Ramirez, Anne Chester

Toxicol Sci· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Species-Specific Urothelial Toxicity With an Anti-HIV Noncatalytic Site Integrase Inhibitor (NCINI) Is Related to Unusual pH-Dependent Physicochemical Changes.
Ruth A Roberts, Richard A Campbell, Phumzile Sikakana, Claire Sadler, Mark Osier, Anne Chester

Toxicol Sci· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical targeting of HIV capsid protein with a long-acting small molecule.
John O Link, Martin S Rhee, Winston C Tse, Jim Zheng, John R Somoza, Anne E Chester

Nature· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Use of Minipigs for Preclinical Safety Assessment by the Pharmaceutical Industry: Results of an IQ DruSafe Minipig Survey.
Curtis Colleton, David Brewster, Anne Chester, David O Clarke, Peter Heining

Toxicol Pathol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis